SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-24-009225
Filing Date
2024-06-17
Accepted
2024-06-17 08:45:18
Documents
51
Period of Report
2024-06-17
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K apre-20240617x8k.htm   iXBRL 8-K 40464
2 EX-99.1 apre-20240617xex99d1.htm EX-99.1 23679
3 EX-99.2 apre-20240617xex99d2.htm EX-99.2 56496
4 GRAPHIC apre-20240617xex99d2g001.jpg GRAPHIC 103640
5 GRAPHIC apre-20240617xex99d2g002.jpg GRAPHIC 335217
6 GRAPHIC apre-20240617xex99d2g003.jpg GRAPHIC 177139
7 GRAPHIC apre-20240617xex99d2g004.jpg GRAPHIC 122443
8 GRAPHIC apre-20240617xex99d2g005.jpg GRAPHIC 140887
9 GRAPHIC apre-20240617xex99d2g006.jpg GRAPHIC 187246
10 GRAPHIC apre-20240617xex99d2g007.jpg GRAPHIC 63178
11 GRAPHIC apre-20240617xex99d2g008.jpg GRAPHIC 142440
12 GRAPHIC apre-20240617xex99d2g009.jpg GRAPHIC 186774
13 GRAPHIC apre-20240617xex99d2g010.jpg GRAPHIC 138333
14 GRAPHIC apre-20240617xex99d2g011.jpg GRAPHIC 180347
15 GRAPHIC apre-20240617xex99d2g012.jpg GRAPHIC 63155
16 GRAPHIC apre-20240617xex99d2g013.jpg GRAPHIC 172058
17 GRAPHIC apre-20240617xex99d2g014.jpg GRAPHIC 108934
18 GRAPHIC apre-20240617xex99d2g015.jpg GRAPHIC 168816
19 GRAPHIC apre-20240617xex99d2g016.jpg GRAPHIC 141007
20 GRAPHIC apre-20240617xex99d2g017.jpg GRAPHIC 112106
21 GRAPHIC apre-20240617xex99d2g018.jpg GRAPHIC 137270
22 GRAPHIC apre-20240617xex99d2g019.jpg GRAPHIC 63393
23 GRAPHIC apre-20240617xex99d2g020.jpg GRAPHIC 232300
24 GRAPHIC apre-20240617xex99d2g021.jpg GRAPHIC 167495
25 GRAPHIC apre-20240617xex99d2g022.jpg GRAPHIC 163322
26 GRAPHIC apre-20240617xex99d2g023.jpg GRAPHIC 165972
27 GRAPHIC apre-20240617xex99d2g024.jpg GRAPHIC 138910
28 GRAPHIC apre-20240617xex99d2g025.jpg GRAPHIC 145511
29 GRAPHIC apre-20240617xex99d2g026.jpg GRAPHIC 91940
30 GRAPHIC apre-20240617xex99d2g027.jpg GRAPHIC 122100
31 GRAPHIC apre-20240617xex99d2g028.jpg GRAPHIC 65608
32 GRAPHIC apre-20240617xex99d2g029.jpg GRAPHIC 169742
33 GRAPHIC apre-20240617xex99d2g030.jpg GRAPHIC 103823
34 GRAPHIC apre-20240617xex99d2g031.jpg GRAPHIC 128039
35 GRAPHIC apre-20240617xex99d2g032.jpg GRAPHIC 88119
36 GRAPHIC apre-20240617xex99d2g033.jpg GRAPHIC 162930
37 GRAPHIC apre-20240617xex99d2g034.jpg GRAPHIC 150877
38 GRAPHIC apre-20240617xex99d2g035.jpg GRAPHIC 155562
  Complete submission text file 0001558370-24-009225.txt   7158219

Data Files

Seq Description Document Type Size
39 EX-101.SCH apre-20240617.xsd EX-101.SCH 3995
40 EX-101.DEF apre-20240617_def.xml EX-101.DEF 2844
41 EX-101.LAB apre-20240617_lab.xml EX-101.LAB 17245
42 EX-101.PRE apre-20240617_pre.xml EX-101.PRE 11355
54 EXTRACTED XBRL INSTANCE DOCUMENT apre-20240617x8k_htm.xml XML 4859
Mailing Address 3805 OLD EASTON ROAD DOYLESTOWN PA 18902
Business Address 3805 OLD EASTON ROAD DOYLESTOWN PA 18902 617-463-9385
Aprea Therapeutics, Inc. (Filer) CIK: 0001781983 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39069 | Film No.: 241047042
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)